Details for New Drug Application (NDA): 208987
✉ Email this page to a colleague
NDA 208987 describes CLARITHROMYCIN, which is a drug marketed by Sandoz, Sun Pharm Inds Ltd, Actavis Labs Fl Inc, Ani Pharms, Dr Reddys Labs Sa, Lupin Ltd, Mpp Pharma, Ranbaxy, Sunshine, Alembic, Aurobindo, Chartwell, Hec Pharm, Hikma, Ivax Sub Teva Pharms, Jubilant Cadista, Novitium Pharma, Pharmobedient, Teva, and Wockhardt, and is included in twenty-three NDAs. It is available from twenty-seven suppliers. Additional details are available on the CLARITHROMYCIN profile page.
The generic ingredient in CLARITHROMYCIN is clarithromycin. There are twenty-one drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the clarithromycin profile page.
The generic ingredient in CLARITHROMYCIN is clarithromycin. There are twenty-one drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the clarithromycin profile page.
Summary for 208987
| Tradename: | CLARITHROMYCIN |
| Applicant: | Sunshine |
| Ingredient: | clarithromycin |
| Patents: | 0 |
Pharmacology for NDA: 208987
| Mechanism of Action | Cytochrome P450 3A Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors |
Medical Subject Heading (MeSH) Categories for 208987
Suppliers and Packaging for NDA: 208987
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CLARITHROMYCIN | clarithromycin | TABLET, EXTENDED RELEASE;ORAL | 208987 | ANDA | Lannett Company, Inc. | 0527-1930 | 0527-1930-06 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0527-1930-06) |
| CLARITHROMYCIN | clarithromycin | TABLET, EXTENDED RELEASE;ORAL | 208987 | ANDA | PD-Rx Pharmaceuticals, Inc. | 43063-942 | 43063-942-14 | 14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-942-14) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 500MG | ||||
| Approval Date: | Jul 9, 2018 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
